Adenovirus-mediated ex vivo immunogene and in vivo combination gene therapy strategies induce a systemic anti-tumor immune defense in the mouse B16 melanoma model

Advances in Experimental Medicine and Biology

Volumn 451, Issue , 1998, Pages 335-343

  Bonnekoh, Bernd ^a,b,d   Greenhalgh, David A ^a   Chen, Shu Hsia ^a,c   Bickenbach, Jackie ^a   Block, Andreas ^a   Rich, Susan S ^a   Krieg, Thomas ^b   Woo, Savio L C ^a,c   Roop, Dennis R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 2; VIRUS VECTOR;

ADENOVIRUS; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GAMMA IRRADIATION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUICIDE GENE; TUMOR GROWTH;

EID: 0031755365     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5357-1_52     Document Type: Article

References (27)

1. B. Bonnekoh, J.R. Bickenbach, D.R. Roop, 1997: Immunological gene therapy approaches for malignant melanoma - Part I: tumor-immunological background. Skin Pharmacol. 10, 49-62
2. B. Bonnekoh, J.R. Bickenbach, D.R. Roop, 1997: Immunological gene therapy approaches for malignant melanoma - Part II: Preclinical studies and clinical strategies. Skin Pharmacol. 10, 105-125
3. B. Bonnekoh, D.A. Greenhalgh, D.S. Bundman, J.N. Eckhardt, M.A. Longley, S.-H. Chen, S.L.C. Woo, D.R. Roop, 1995: Inhibition of melanoma growth by adenoviral-mediated HSV thymidine kinase gene transfer in vivo. J. Invest. Dermatol. 104, 313-317
4. B. Bonnekoh, D.A. Greenhalgh, S.-H. Chen, S.S. Rich, S.L.C. Woo, D.R. Roop, 1995: Adenoviral-mediated combination gene therapy for treatment of experimental malignant melanoma in vivo. J Invest. Dermatol. 104, 597
5. B. Bonnekoh, D.A. Greenhalgh, D.S. Bundman, K. Kosai, S.-H. Chen, M.J. Finegold, T. Krieg, S.L.C. Woo, D.R. Roop, 1996: Adenoviral-mediated herpes simplex virus-thymidine kinase gene transfer in vivo for treatment of experimental human melanoma. J. Invest. Dermatol. 106, 1163-1168
6. R.G. Crystal, 1995: The gene as a drug. Nature Med. 1, 15-17
7. R.C. Mulligan, 1993: The basic science of gene therapy. Science 260, 926-932
8. F.L. Graham, L. Prevec, 1991: Manipulation of adenovirus vectors. Meth. Mol. Biol. 7, 109-128
9. nd. ed. Philadelphia: Lippincott, pp. 713-726.
10. E.J. Kremer, M. Perricaudet, 1995: Adenoviruses and adeno-associated virus mediated gene transfer. Br. Med. Bull. 51, 31-14
11. P.W. Chen, M. Wang, V. Bronte, Y. Zhai, S.A. Rosenberg, N.P. Restifo, 1996: Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. J. Immunol. 156, 224-231
12. H.X. Qin, S.K. Chatterjee, 1996: Construction of recombinant vaccinia virus expressing GM-CSF and its use as tumor vaccine. Gene Ther. 3, 59-66
13. A.J. Bett, W. Haddara, L. Prevec, F.L. Graham, 1994: An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91, 8802-8806
14. J.L. Bramson, F.L. Graham, J. Gauldie, 1995: The use of adenoviral vectors for gene therapy and gene transfer in vivo. Curr. Opin. Biotech. 6, 590-595
15. S.H. Chen, X.H.L. Chen, Y. Wang, K. Kosai, M.J. Finegold, S.S. Rich, S.L.C. Woo, 1995: Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc. Natl. Acad. Sci. USA 92, 2577-2581
16. C.L. Addison, T. Braciak, R. Ralston, W.J. Muller, J. Gauldie, F.L. Graham, 1995: Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model. Proc. Natl. Acad. Sci. USA 92, 8522-8526
17. L. Cordier, M.-T. Duffour, J.-C. Sabourin, M.G. Lee, J. Cabannes, T. Ragot, M. Perricaudet, H. Haddada, 1995: Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene. Gene Ther. 2, 16-21
18. H. Huang, S.-H. Chen, K.-I. Kosai, M.J. Finegold, S.L.C. Woo, 1996: Gene therapy for hepatocellular carcinoma: long-term remission of primary and metastatic tumors in mice by interleukin-2 gene therapy in vivo. Gene Ther 3, 980-987
19. G.J. Nabel, 1994: Immunotherapy for cancer by direct gene transfer into tumors. Hum. Gene Ther. 5, 57-77
20. I.E. Alexander, D.W. Russell, A.M. Spence, A.D. Miller, 1996: Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum. Gene Ther. 7, 841-850
21. B. Bonnekoh, D.A. Greenhalgh, S.-H. Chen, A. Block, S.S. Rich, T. Krieg, S.L.C. Woo, D.R. Roop, 1997: Ex vivo and in vivo adenovirus-mediated gene therapy strategies induce a systemic anti-tumor immune defence in the B16 melanoma model. J. Invest. Dermatol. submitted
22. H. Haddada, T. Ragot, L. Cordier, M.T. Duffour, M. Perricaudet, 1993: Adenoviral interleukin-2 gene transfer into P815 tumor cells abrogates tumorigenicity and induces antitumoral immunity in mice. Hum. Gene Ther. 4, 703-711
23. G. Dranoff, E. Jaffee, A. Lazenby, P. Golumbek, H. Levitsky, K. Brose, V. Jackson, H. Hamada, D. Pardoll, R.C. Mulligan, 1993: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90, 3539-3543
24. Y. Zhai, J.C. Yang, Y. Kawakami, P. Spiess, S.C. Wadsworth, L.M. Cardoza, L.A. Couture, A.E. Smith, S.A. Rosenberg, 1996: Antigen-specific tumor vaccines - Development and characterization of recombinant adenoviruses encoding MARTI or gp 100 for cancer therapy. J. Immunol. 156, 700-710
25. J.M. Wilson, 1996: Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334, 1185-1187
26. B. Bonnekoh, D.A. Greenhalgh, S.-H. Chen, S.L.C. Woo, D.R. Roop, 1997: Vaccination with melanoma cells xenogenized by a recombinant adenovirus provides a protection against tumor challenge in the murine K1735 model. J. Invest. Dermatol. 109, 417
27. S. Kochanek, P.R. Clemens, K. Mitani, H.-H. Chen, S. Chan, C.T. Caskey, 1996: A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc. Natl. Acad. Sci. USA 93, 5731-5736